TSXV:VER.H - Post by User
Post by
herbaciouson Apr 28, 2011 8:56am
251 Views
Post# 18499327
ZACKS EQUITY RESEARCH
ZACKS EQUITY RESEARCHOn febuary 4 2011, Zacks initiated coverage of Verisante Technology. with am outperform of 40% since there initiation and they continue to believe the stock remains SIGNIFICANTLY UNDERVALUED.
$2.10 to $2.25 as a result of comp valuations moving higher since their initial report
VERISANTE EXPECTS TO HAVE ISO 13485:2003 CERTIFICATION< HEALTH CANADA APPROVAL AND CE MARK COMMENSURATE WITH THEIR INITIAL ASSUMPTIONS>
Timing is everything!
the share price is perfect for accumilation
do your own due diligence
herb